Dec 23 (Reuters) - Immuron Ltd IMC.AX :
* IMMURON RECEIVES FDA APPROVAL FOR TRAVELAN IND APPLICATION
* IMMURON LTD - PLANS IN PLACE TO INITIATE A HUMAN CLINICAL
TRIAL
IN 60 HEALTHY VOLUNTEERS IN USA
* IMMURON LTD - PLANS IN PLACE TO INITIATE A HUMAN CLINICAL
TRIAL
IN 60 HEALTHY VOLUNTEERS IN USA
* IMMURON LTD - RECRUITMENT IS PLANNED TO BE INITIATED IN 1H
2023
WITH HEADLINE RESULTS FROM CLINICAL TRIAL EXPECTED TO BE
REPORTED BY YEAR END 2023
Source text for Eikon: ID:nGNX5P25xB
Further company coverage: IMC.AX
((Reuters.Briefs@thomsonreuters.com;))